Multiplex Assays: Revolutionizing Diagnostics with Automated, Accurate, and Cost-Effective Solutions
The global multiplex assays market is projected to experience robust growth in the coming years, driven by the increasing advantages of multiplex assays over traditional singleplex and conventional assays. According to a new research study, the market was valued at $3.5 billion in 2022 and is expected to reach $5.3 billion by 2027, growing at a compound annual growth rate (CAGR) of 8.8% during the forecast period. Multiplex assays offer several benefits over conventional methods, including automation, convenience, accuracy, and reproducibility. These assays allow for the simultaneous measurement of multiple analytes in a single sample, reducing the overall cost and time per assay. Bead-based microplate assays, in particular, provide a greater surface area for binding with lower background signals compared to traditional ELISA techniques, and the beads can be coded for use in multiplex assays. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314...